These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 30537741)

  • 1. Type I Interferons: Distinct Biological Activities and Current Applications for Viral Infection.
    Li SF; Gong MJ; Zhao FR; Shao JJ; Xie YL; Zhang YG; Chang HY
    Cell Physiol Biochem; 2018; 51(5):2377-2396. PubMed ID: 30537741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral potential of medicinal plants against HIV, HSV, influenza, hepatitis, and coxsackievirus: A systematic review.
    Akram M; Tahir IM; Shah SMA; Mahmood Z; Altaf A; Ahmad K; Munir N; Daniyal M; Nasir S; Mehboob H
    Phytother Res; 2018 May; 32(5):811-822. PubMed ID: 29356205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of antiviral effect of type I, II, and III interferons on direct-acting antiviral-resistant hepatitis C virus.
    Hamana A; Takahashi Y; Uchida T; Nishikawa M; Imamura M; Chayama K; Takakura Y
    Antiviral Res; 2017 Oct; 146():130-138. PubMed ID: 28864074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type I interferons in the pathogenesis and treatment of canine diseases.
    Klotz D; Baumgärtner W; Gerhauser I
    Vet Immunol Immunopathol; 2017 Sep; 191():80-93. PubMed ID: 28895871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Viruses and antiviral drug resistance].
    Hovi T; Järvinen A; Pyhälä R; Ristola M; Salminen M
    Duodecim; 2002; 118(9):911-8. PubMed ID: 12238169
    [No Abstract]   [Full Text] [Related]  

  • 6. Pandemic 2009 H1N1 influenza virus is resistant to the antiviral activity of several interferon alpha subtypes.
    Scagnolari C; Trombetti S; Soldà A; Selvaggi C; Monteleone K; Spano L; Pierangeli A; Clementi M; Turriziani O; Antonelli G
    J Interferon Cytokine Res; 2011 Jun; 31(6):475-9. PubMed ID: 21235413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral activity of CHO-SS cell-derived human omega interferon and other human interferons against HCV RNA replicons and related viruses.
    Buckwold VE; Wei J; Huang Z; Huang C; Nalca A; Wells J; Russell J; Collins B; Ptak R; Lang W; Scribner C; Blanchett D; Alessi T; Langecker P
    Antiviral Res; 2007 Feb; 73(2):118-25. PubMed ID: 16987555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Type I IFNs in Influenza: Antiviral Superheroes or Immunopathogenic Villains?
    Wu W; Metcalf JP
    J Innate Immun; 2020; 12(6):437-447. PubMed ID: 32564033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is hepatitis virus resistance to antiviral drugs a threat?
    Pawlotsky JM
    Gastroenterology; 2012 May; 142(6):1369-72. PubMed ID: 22537445
    [No Abstract]   [Full Text] [Related]  

  • 10. Part XIV. Antiviral agents other than antiretrovirals: therapy for herpesvirus infections, viral hepatitis, and influenza.
    Lockhart SM; Salvaggio MR; Bronze MS; Greenfield RA
    J Okla State Med Assoc; 2007 Oct; 100(10):388-95. PubMed ID: 18085096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral potential of exogenous human omega interferon to inhibit pandemic 2009 A (H1N1) influenza virus.
    Xu C; Song X; Fu L; Dong D; Wu S; Li G; Yi S; Yu T; Yu R; Hou L; Chen W
    Viral Immunol; 2011 Oct; 24(5):369-74. PubMed ID: 22004136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferons: Success in anti-viral immunotherapy.
    Lin FC; Young HA
    Cytokine Growth Factor Rev; 2014 Aug; 25(4):369-76. PubMed ID: 25156421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferons, interferon-like cytokines, and their receptors.
    Pestka S; Krause CD; Walter MR
    Immunol Rev; 2004 Dec; 202():8-32. PubMed ID: 15546383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral potential of interferon-omega on hepatitis B virus replication in human hepatoma cells.
    Hagelstein J; Kist A; Stremmel W; Galle PR
    Arzneimittelforschung; 1998 Mar; 48(3):343-7. PubMed ID: 9553691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-tau: current applications and potential in antiviral therapy.
    Chon TW; Bixler S
    J Interferon Cytokine Res; 2010 Jul; 30(7):477-85. PubMed ID: 20626290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose interferon Type I treatment is effective against H5N1 and swine-origin H1N1 influenza A viruses in vitro and in vivo.
    Haasbach E; Droebner K; Vogel AB; Planz O
    J Interferon Cytokine Res; 2011 Jun; 31(6):515-25. PubMed ID: 21323570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Cytokinome Analysis for Interferon Response.
    Al-Yahya S; Mahmoud L; Al-Zoghaibi F; Al-Tuhami A; Amer H; Almajhdi FN; Polyak SJ; Khabar KS
    J Virol; 2015 Jul; 89(14):7108-19. PubMed ID: 25926649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somnogenic effects of rabbit and recombinant human interferons in rabbits.
    Kimura M; Majde JA; Toth LA; Opp MR; Krueger JM
    Am J Physiol; 1994 Jul; 267(1 Pt 2):R53-61. PubMed ID: 7519411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon and interferon-stimulated genes in HBV treatment.
    Li Q; Sun B; Zhuo Y; Jiang Z; Li R; Lin C; Jin Y; Gao Y; Wang D
    Front Immunol; 2022; 13():1034968. PubMed ID: 36531993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IFN-α subtypes: distinct biological activities in anti-viral therapy.
    Gibbert K; Schlaak JF; Yang D; Dittmer U
    Br J Pharmacol; 2013 Mar; 168(5):1048-58. PubMed ID: 23072338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.